Please assess the completion status of the following clinical trial:

Trial Title: ERAS Protocol in Pancreaticoduodenectomy and Total Pancreatectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All PD or TP patients 18-99 years old~Exclusion Criteria:~* Any other surgery than PD or TP~* High risk patients~* Refusal for the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Enchanced recovery after surgery protocol (Type: EXPERIMENTAL): ERAS-protocol as described in low risk patients after pancreaticoduodenectomy or total pancreatectomy
- Standard protocol (Type: NO_INTERVENTION): Standard recovery protocol after pancreaticoduodenectomy or total pancreatectomy

Based on this trial design, predict the completion outcome and termination type (if applicable).